Profound Research Announces Leadership Team Expansion with New CEO and Key Promotions

Photo Credit: Profound Research

NASHVILLE, Tenn., February 8, 2024 (VSNewsNetwork.com) - According to an announcement from Profound Research, a clinical trial site network, the company has appointed Lora Parahovnik, Ph.D., MBA, as its new Chief Executive Officer. In addition, Profound Research has promoted Marty Anderson to Chief Operations Officer and Christopher Church to Chief Commercial Officer, as part of its strategy to drive growth and foster innovation.

Lora Parahovnik, who previously held the position of CEO at Accel Research Sites Network, brings a comprehensive background in clinical research to Profound Research. Parahovnik shared her enthusiasm about her new role, stating, "I am honored to join an organization with a vision deeply rooted in improving patient lives, ensuring access to innovative treatments, and propelling scientific and medical progress."

Marty Anderson, now the Chief Operations Officer, has been integral to Profound Research's operational strategy from the company's early days. With over three decades of experience in the clinical trial industry, Anderson's promotion is seen as a key move in sustaining the company's operational excellence and market expansion.

Christopher Church's elevation to Chief Commercial Officer recognizes his significant contributions to the company's commercial strategy and business development. Church's expertise is expected to continue driving Profound Research's therapeutic area expansion and revenue growth.

Dr. Jonathan Feldstein, President and co-founder of Profound Research, commented on the leadership appointments, saying, "We are thrilled to welcome Lora Parahovnik as our CEO and to announce the well-deserved promotions of Marty Anderson and Christopher Church. Their combined ability and leadership will be instrumental in driving Profound Research forward as an industry leader dedicated to medical innovation and patient access to those treatments.”

These leadership appointments underscore Profound Research's commitment to advancing clinical trials and medical research through strategic management and innovation.

For additional information about Profound Research and its leadership team, visit www.profoundresearch.com.

Source: Profound Research via Newswire